Concepts (276)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stress Disorders, Post-Traumatic | 49 | 2023 | 547 | 8.480 |
Why?
|
| Sleep | 22 | 2022 | 179 | 4.810 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 12 | 2022 | 70 | 4.580 |
Why?
|
| Sleep, REM | 9 | 2017 | 11 | 1.860 |
Why?
|
| Autonomic Nervous System | 5 | 2019 | 38 | 1.790 |
Why?
|
| Fear | 7 | 2022 | 271 | 1.550 |
Why?
|
| Polysomnography | 13 | 2019 | 41 | 1.440 |
Why?
|
| Urban Population | 6 | 2016 | 364 | 1.420 |
Why?
|
| Heart Rate | 6 | 2019 | 261 | 1.230 |
Why?
|
| Veterans | 6 | 2018 | 203 | 1.220 |
Why?
|
| Wounds and Injuries | 6 | 2015 | 191 | 1.130 |
Why?
|
| Circadian Rhythm | 4 | 2016 | 234 | 1.110 |
Why?
|
| Young Adult | 22 | 2024 | 4936 | 1.110 |
Why?
|
| Humans | 75 | 2024 | 42163 | 1.010 |
Why?
|
| Adult | 44 | 2024 | 13458 | 0.930 |
Why?
|
| Resilience, Psychological | 2 | 2016 | 89 | 0.860 |
Why?
|
| Stress, Psychological | 5 | 2018 | 641 | 0.830 |
Why?
|
| Male | 50 | 2024 | 22779 | 0.820 |
Why?
|
| Female | 48 | 2024 | 24018 | 0.790 |
Why?
|
| Adolescent | 21 | 2024 | 5950 | 0.760 |
Why?
|
| Polymorphism, Genetic | 2 | 2016 | 200 | 0.750 |
Why?
|
| Anxiety Disorders | 5 | 2023 | 319 | 0.690 |
Why?
|
| Psychiatric Status Rating Scales | 6 | 2018 | 280 | 0.680 |
Why?
|
| Antipsychotic Agents | 5 | 2008 | 81 | 0.620 |
Why?
|
| Autonomic Nervous System Diseases | 2 | 2016 | 12 | 0.620 |
Why?
|
| Blood Pressure | 2 | 2015 | 662 | 0.600 |
Why?
|
| Sleep Paralysis | 2 | 2008 | 2 | 0.580 |
Why?
|
| Inflammation Mediators | 2 | 2017 | 138 | 0.580 |
Why?
|
| Arousal | 2 | 2019 | 95 | 0.580 |
Why?
|
| Perception | 1 | 2019 | 209 | 0.540 |
Why?
|
| Residence Characteristics | 2 | 2018 | 359 | 0.540 |
Why?
|
| Military Personnel | 1 | 2018 | 109 | 0.540 |
Why?
|
| Darkness | 1 | 2017 | 28 | 0.530 |
Why?
|
| Hydrocortisone | 2 | 2014 | 89 | 0.510 |
Why?
|
| Period Circadian Proteins | 1 | 2016 | 37 | 0.510 |
Why?
|
| Sleep Stages | 1 | 2016 | 6 | 0.500 |
Why?
|
| Emotions | 1 | 2019 | 251 | 0.490 |
Why?
|
| Receptors, Odorant | 1 | 2016 | 44 | 0.480 |
Why?
|
| Severity of Illness Index | 9 | 2016 | 708 | 0.480 |
Why?
|
| Risperidone | 2 | 2006 | 5 | 0.470 |
Why?
|
| Obesity | 2 | 2014 | 1131 | 0.470 |
Why?
|
| Combat Disorders | 2 | 2006 | 12 | 0.470 |
Why?
|
| Research Design | 4 | 2013 | 370 | 0.460 |
Why?
|
| Theta Rhythm | 1 | 2014 | 10 | 0.430 |
Why?
|
| Hypnotics and Sedatives | 2 | 2005 | 27 | 0.430 |
Why?
|
| Risk Factors | 11 | 2016 | 3942 | 0.420 |
Why?
|
| Academies and Institutes | 1 | 2013 | 39 | 0.410 |
Why?
|
| Survivors | 2 | 2012 | 152 | 0.410 |
Why?
|
| Middle Aged | 25 | 2024 | 11819 | 0.400 |
Why?
|
| Electrocardiography | 4 | 2018 | 184 | 0.400 |
Why?
|
| Life Change Events | 6 | 2012 | 107 | 0.400 |
Why?
|
| Cytokines | 1 | 2017 | 661 | 0.400 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2013 | 48 | 0.390 |
Why?
|
| Minority Health | 1 | 2013 | 96 | 0.390 |
Why?
|
| Comorbidity | 8 | 2014 | 725 | 0.390 |
Why?
|
| DNA Methylation | 1 | 2016 | 393 | 0.390 |
Why?
|
| Cooperative Behavior | 2 | 2013 | 250 | 0.380 |
Why?
|
| Amygdala | 1 | 2013 | 125 | 0.370 |
Why?
|
| Cognition Disorders | 1 | 2014 | 243 | 0.370 |
Why?
|
| Weight Loss | 1 | 2013 | 138 | 0.370 |
Why?
|
| Minority Groups | 2 | 2014 | 663 | 0.360 |
Why?
|
| Community-Institutional Relations | 1 | 2013 | 208 | 0.360 |
Why?
|
| Time Factors | 6 | 2017 | 1848 | 0.350 |
Why?
|
| Depressive Disorder | 3 | 2008 | 185 | 0.330 |
Why?
|
| Fatigue | 1 | 2011 | 97 | 0.330 |
Why?
|
| Mental Health | 2 | 2024 | 363 | 0.320 |
Why?
|
| Wakefulness | 4 | 2018 | 23 | 0.320 |
Why?
|
| Universities | 1 | 2013 | 539 | 0.320 |
Why?
|
| Sleep Deprivation | 2 | 2008 | 29 | 0.320 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2009 | 15 | 0.300 |
Why?
|
| Bipolar Disorder | 2 | 2007 | 83 | 0.300 |
Why?
|
| Healthcare Disparities | 2 | 2013 | 573 | 0.300 |
Why?
|
| Receptors, Serotonin | 1 | 2009 | 25 | 0.290 |
Why?
|
| Mental Recall | 1 | 2009 | 81 | 0.290 |
Why?
|
| Conditioning, Classical | 1 | 2009 | 67 | 0.290 |
Why?
|
| Alleles | 1 | 2009 | 352 | 0.270 |
Why?
|
| Extinction, Psychological | 1 | 2009 | 103 | 0.270 |
Why?
|
| Prevalence | 6 | 2015 | 1597 | 0.260 |
Why?
|
| Health Status Disparities | 1 | 2013 | 705 | 0.260 |
Why?
|
| Cross-Sectional Studies | 6 | 2018 | 3077 | 0.260 |
Why?
|
| Sympathetic Nervous System | 3 | 2017 | 64 | 0.250 |
Why?
|
| Dyssomnias | 1 | 2006 | 2 | 0.250 |
Why?
|
| Trauma Severity Indices | 2 | 2016 | 31 | 0.240 |
Why?
|
| District of Columbia | 3 | 2014 | 73 | 0.240 |
Why?
|
| Actigraphy | 2 | 2018 | 17 | 0.240 |
Why?
|
| Double-Blind Method | 4 | 2022 | 305 | 0.240 |
Why?
|
| Stress Disorders, Traumatic, Acute | 1 | 2005 | 2 | 0.230 |
Why?
|
| Triazoles | 2 | 2022 | 100 | 0.220 |
Why?
|
| Alcoholism | 2 | 2008 | 292 | 0.220 |
Why?
|
| Prazosin | 2 | 2018 | 9 | 0.210 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2004 | 44 | 0.210 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 4 | 2009 | 116 | 0.210 |
Why?
|
| Drug Prescriptions | 1 | 2003 | 60 | 0.200 |
Why?
|
| Breast Neoplasms | 2 | 2012 | 1679 | 0.200 |
Why?
|
| Temazepam | 1 | 2002 | 1 | 0.200 |
Why?
|
| Saliva | 2 | 2014 | 115 | 0.190 |
Why?
|
| Accidents, Traffic | 1 | 2002 | 46 | 0.190 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 2 | 2015 | 65 | 0.190 |
Why?
|
| Primary Health Care | 4 | 2011 | 362 | 0.190 |
Why?
|
| Azepines | 1 | 2022 | 22 | 0.190 |
Why?
|
| Psychotherapy | 4 | 2018 | 56 | 0.180 |
Why?
|
| United States | 9 | 2024 | 5072 | 0.180 |
Why?
|
| Case-Control Studies | 3 | 2016 | 1266 | 0.180 |
Why?
|
| Learning | 1 | 2021 | 155 | 0.160 |
Why?
|
| Dreams | 2 | 2018 | 10 | 0.160 |
Why?
|
| Aged | 10 | 2024 | 7982 | 0.150 |
Why?
|
| Anxiety | 3 | 2023 | 847 | 0.150 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2004 | 471 | 0.150 |
Why?
|
| Prospective Studies | 3 | 2024 | 1574 | 0.150 |
Why?
|
| Psychometrics | 3 | 2014 | 350 | 0.150 |
Why?
|
| Afghanistan | 1 | 2018 | 6 | 0.150 |
Why?
|
| Iraq | 1 | 2018 | 8 | 0.150 |
Why?
|
| Afghan Campaign 2001- | 1 | 2018 | 14 | 0.150 |
Why?
|
| Poverty | 1 | 2022 | 395 | 0.150 |
Why?
|
| Health Services Research | 2 | 2013 | 161 | 0.150 |
Why?
|
| Cognition | 1 | 2022 | 458 | 0.140 |
Why?
|
| Pilot Projects | 3 | 2012 | 733 | 0.140 |
Why?
|
| Drug Therapy, Combination | 4 | 2008 | 233 | 0.140 |
Why?
|
| Risk Assessment | 2 | 2024 | 845 | 0.140 |
Why?
|
| Treatment Outcome | 6 | 2010 | 1586 | 0.130 |
Why?
|
| Implosive Therapy | 1 | 2016 | 14 | 0.130 |
Why?
|
| Medical Records | 2 | 2007 | 48 | 0.130 |
Why?
|
| Cardiovascular Diseases | 3 | 2015 | 729 | 0.130 |
Why?
|
| Panic Disorder | 2 | 2008 | 102 | 0.120 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2013 | 106 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2017 | 165 | 0.120 |
Why?
|
| C-Reactive Protein | 1 | 2017 | 164 | 0.120 |
Why?
|
| Receptors, GABA-A | 1 | 2016 | 65 | 0.120 |
Why?
|
| Prognosis | 2 | 2015 | 850 | 0.120 |
Why?
|
| Role | 1 | 2015 | 10 | 0.120 |
Why?
|
| Adaptation, Psychological | 2 | 2016 | 410 | 0.120 |
Why?
|
| Violence | 1 | 2016 | 133 | 0.120 |
Why?
|
| Vietnam | 2 | 2006 | 61 | 0.120 |
Why?
|
| Monitoring, Ambulatory | 1 | 2014 | 14 | 0.110 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 236 | 0.110 |
Why?
|
| Sex Distribution | 1 | 2015 | 224 | 0.110 |
Why?
|
| Age Distribution | 1 | 2015 | 249 | 0.110 |
Why?
|
| Retrospective Studies | 3 | 2013 | 2485 | 0.110 |
Why?
|
| Down-Regulation | 1 | 2016 | 452 | 0.110 |
Why?
|
| Vitamin D | 1 | 2016 | 196 | 0.110 |
Why?
|
| Fourier Analysis | 1 | 2014 | 45 | 0.110 |
Why?
|
| Florida | 2 | 2007 | 461 | 0.110 |
Why?
|
| Models, Organizational | 1 | 2013 | 35 | 0.100 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 274 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2016 | 534 | 0.100 |
Why?
|
| Interdisciplinary Communication | 1 | 2013 | 40 | 0.100 |
Why?
|
| Follow-Up Studies | 3 | 2006 | 1051 | 0.100 |
Why?
|
| Length of Stay | 2 | 2012 | 231 | 0.100 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 281 | 0.100 |
Why?
|
| Electroencephalography | 1 | 2014 | 135 | 0.100 |
Why?
|
| Acute Disease | 2 | 2023 | 156 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2017 | 916 | 0.100 |
Why?
|
| Program Development | 1 | 2013 | 237 | 0.100 |
Why?
|
| Waist Circumference | 1 | 2013 | 90 | 0.100 |
Why?
|
| Colonic Polyps | 1 | 2013 | 70 | 0.100 |
Why?
|
| Aged, 80 and over | 4 | 2013 | 2803 | 0.090 |
Why?
|
| Logistic Models | 1 | 2015 | 1001 | 0.090 |
Why?
|
| Adenoma | 1 | 2013 | 94 | 0.090 |
Why?
|
| Child | 4 | 2014 | 3381 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2015 | 1729 | 0.090 |
Why?
|
| Vulnerable Populations | 1 | 2013 | 163 | 0.090 |
Why?
|
| Chronic Disease | 2 | 2006 | 541 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2016 | 1265 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 150 | 0.090 |
Why?
|
| Religion | 1 | 2012 | 90 | 0.090 |
Why?
|
| Life Style | 1 | 2013 | 326 | 0.090 |
Why?
|
| Linear Models | 1 | 2011 | 311 | 0.080 |
Why?
|
| Piperazines | 2 | 2008 | 117 | 0.080 |
Why?
|
| Cyclonic Storms | 1 | 2011 | 75 | 0.080 |
Why?
|
| Hospital Mortality | 1 | 2012 | 206 | 0.080 |
Why?
|
| Wounds, Penetrating | 1 | 2010 | 22 | 0.080 |
Why?
|
| Diagnosis, Differential | 2 | 2008 | 236 | 0.080 |
Why?
|
| New Hampshire | 2 | 2007 | 5 | 0.080 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2010 | 31 | 0.080 |
Why?
|
| Inflammation | 1 | 2015 | 729 | 0.080 |
Why?
|
| Medically Uninsured | 1 | 2010 | 64 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2012 | 253 | 0.080 |
Why?
|
| Models, Biological | 1 | 2013 | 711 | 0.080 |
Why?
|
| Dementia | 1 | 2011 | 155 | 0.080 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2009 | 3 | 0.080 |
Why?
|
| Insurance Coverage | 1 | 2010 | 108 | 0.080 |
Why?
|
| Health Status | 1 | 2013 | 432 | 0.080 |
Why?
|
| Generalization, Stimulus | 1 | 2009 | 1 | 0.080 |
Why?
|
| Convalescence | 1 | 2008 | 7 | 0.080 |
Why?
|
| Neuroleptic Malignant Syndrome | 1 | 2008 | 2 | 0.080 |
Why?
|
| Insurance, Health | 1 | 2010 | 143 | 0.070 |
Why?
|
| Quinolones | 1 | 2008 | 13 | 0.070 |
Why?
|
| Benzodiazepines | 1 | 2008 | 19 | 0.070 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2008 | 15 | 0.070 |
Why?
|
| Aggression | 1 | 2008 | 101 | 0.070 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 2008 | 27 | 0.070 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2007 | 29 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 502 | 0.070 |
Why?
|
| Nipecotic Acids | 1 | 2007 | 2 | 0.070 |
Why?
|
| Depressive Disorder, Major | 1 | 2009 | 128 | 0.070 |
Why?
|
| GABA Agonists | 1 | 2007 | 21 | 0.070 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2006 | 25 | 0.060 |
Why?
|
| Drug Therapy | 1 | 2006 | 17 | 0.060 |
Why?
|
| Domestic Violence | 1 | 2006 | 32 | 0.060 |
Why?
|
| Genotype | 1 | 2009 | 796 | 0.060 |
Why?
|
| Health Surveys | 1 | 2008 | 401 | 0.060 |
Why?
|
| Age Factors | 1 | 2009 | 1139 | 0.060 |
Why?
|
| Gene Expression | 1 | 2009 | 692 | 0.060 |
Why?
|
| Sex Factors | 1 | 2009 | 1008 | 0.060 |
Why?
|
| Risk-Taking | 1 | 2008 | 456 | 0.060 |
Why?
|
| Registries | 1 | 2007 | 431 | 0.060 |
Why?
|
| Dissociative Disorders | 1 | 2005 | 18 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 727 | 0.060 |
Why?
|
| Antidepressive Agents | 1 | 2005 | 61 | 0.060 |
Why?
|
| Emergency Medical Services | 1 | 2024 | 79 | 0.050 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2004 | 6 | 0.050 |
Why?
|
| Sertraline | 1 | 2004 | 7 | 0.050 |
Why?
|
| Community Mental Health Centers | 1 | 2003 | 2 | 0.050 |
Why?
|
| Mass Screening | 2 | 2024 | 531 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2005 | 225 | 0.050 |
Why?
|
| Incidence | 3 | 2013 | 1054 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 242 | 0.050 |
Why?
|
| Hypertension | 1 | 2009 | 823 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2024 | 268 | 0.050 |
Why?
|
| Schizophrenic Psychology | 1 | 2002 | 16 | 0.050 |
Why?
|
| Animals | 3 | 2015 | 16695 | 0.050 |
Why?
|
| Antigens, Viral | 1 | 2021 | 50 | 0.050 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 51 | 0.040 |
Why?
|
| Injury Severity Score | 2 | 2012 | 69 | 0.040 |
Why?
|
| Schizophrenia | 1 | 2002 | 91 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 1112 | 0.040 |
Why?
|
| Disease Progression | 1 | 2023 | 661 | 0.040 |
Why?
|
| Psychotic Disorders | 1 | 2002 | 69 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2024 | 377 | 0.040 |
Why?
|
| Health Policy | 1 | 2002 | 184 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 602 | 0.040 |
Why?
|
| Substance-Related Disorders | 1 | 2008 | 825 | 0.040 |
Why?
|
| Depression | 1 | 2006 | 837 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2002 | 1020 | 0.040 |
Why?
|
| Hospitalization | 1 | 2002 | 482 | 0.040 |
Why?
|
| Hospitals, Veterans | 1 | 2018 | 16 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2010 | 438 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2018 | 61 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2014 | 1516 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 174 | 0.030 |
Why?
|
| Renin-Angiotensin System | 1 | 2015 | 44 | 0.030 |
Why?
|
| Women | 1 | 2012 | 28 | 0.020 |
Why?
|
| Database Management Systems | 1 | 2012 | 19 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2012 | 17 | 0.020 |
Why?
|
| New Orleans | 1 | 2011 | 17 | 0.020 |
Why?
|
| Research Support as Topic | 1 | 2012 | 89 | 0.020 |
Why?
|
| Psychotropic Drugs | 1 | 2011 | 17 | 0.020 |
Why?
|
| Trauma Centers | 1 | 2012 | 92 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 487 | 0.020 |
Why?
|
| Motor Activity | 1 | 2013 | 438 | 0.020 |
Why?
|
| Craniocerebral Trauma | 1 | 2010 | 22 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 225 | 0.020 |
Why?
|
| Mental Health Services | 1 | 2011 | 134 | 0.020 |
Why?
|
| Benztropine | 1 | 2008 | 1 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2008 | 30 | 0.020 |
Why?
|
| Psychology | 1 | 2008 | 39 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2010 | 336 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 638 | 0.020 |
Why?
|
| Demography | 1 | 2008 | 195 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2013 | 585 | 0.020 |
Why?
|
| Quality of Life | 1 | 2012 | 599 | 0.020 |
Why?
|
| Personality Assessment | 1 | 2007 | 44 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2007 | 112 | 0.020 |
Why?
|
| Diet | 1 | 2013 | 810 | 0.020 |
Why?
|
| REM Sleep Parasomnias | 1 | 2006 | 1 | 0.020 |
Why?
|
| Infant | 1 | 2010 | 1143 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2006 | 40 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2005 | 47 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2005 | 116 | 0.010 |
Why?
|
| Cause of Death | 1 | 2005 | 183 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2005 | 512 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 1058 | 0.010 |
Why?
|
| Critical Pathways | 1 | 2002 | 18 | 0.010 |
Why?
|
| Drug Utilization | 1 | 2002 | 34 | 0.010 |
Why?
|
| Forecasting | 1 | 2002 | 136 | 0.010 |
Why?
|
| Medicaid | 1 | 2002 | 138 | 0.010 |
Why?
|